Application of CRISPR/Cas9 in the Disease Treatment
DOI:
https://doi.org/10.54097/7a7csg20Keywords:
CRISPR/cas9; blood disease, neurodegenerative disorder, cancer.Abstract
CRISPR/cas9 was widely used in medical study because it is fast, cheap, accurate, and efficient in knockout, knock-in, activation, interference and other editing functions. It has gained attention for precise and effect DNA pieces targeting and editing in different kind model systems, including rat, rabbit, and human cells. The paper will going to investigating how Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is used to solve human disease. Most of the DNA mutation linked to a hereditary illness can be edited using CRISPR and CRISPR-associated protein 9 technology. The following articles will not only talk about disease associated with gene mutations, but also solve disease by changing DNA sequences and removing allergy factor form food. To explain several of the above approaches, a few examples have been selected for this article, including Alzheimer's disease, Hemophilia, Tyrosine, Beta thalassemia, Parkinson's disease, Hepatocellular carcinoma, and Beta Lactoglobulin.
Downloads
References
Lu, L., Xi, Y., Cai, Y., Sun, M., & Yang, H. (2021). Application of CRISPR/Cas9 in Alzheimer’s Disease. Frontiers in Neuroscience, 15. https://doi.org/10.3389/fnins.2021.803894
Jeong Pil Han, Kim, M., Choi, B., Jeong Hyeon Lee, Geon Seong Lee, Jeong, M., Lee, Y., Kim, E.-A., Oh, H.-K., Go, N., Lee, H.-R., Kyu Jun Lee, Un Gi Kim, Jae Young Lee, Kim, S., Chang, J., Lee, H., Dong Woo Song, & Su Cheong Yeom. (2022). In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy. Science Advances, 8(3). https://doi.org/10.1126/sciadv.abj6901
Ali, S., Mumtaz, S., Hafiz Abdullah Shakir, Muhammad Ali Khan, Hafız Muhammad Tahir, Mumtaz, S., Tafail Akbar Mughal, Hassan, A., Syed, Irfan, M., & Muhammad. (2021). Current status of beta‐thalassemia and its treatment strategies. Molecular Genetics & Genomic Medicine, 9(12). https://doi.org/10.1002/mgg3.1788
Fu, B., Liao, J., Chen, S., Li, W., Wang, Q., Hu, J., Yang, F., Hsiao, S., Jiang, Y., Wang, L., Chen, F., Zhang, Y., Wang, X., Li, D., Liu, M., & Wu, Y. (2022). CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia. Nature Medicine, 28(8), 1573–1580. https://doi.org/10.1038/s41591-022-01906-z
Raed Ibraheim, Phillip, Mir, A., Javeed, N., Wang, J., Tomás Rodríguez, Namkung, S., Nelson, S. M., Eraj Shafiq Khokhar, Mintzer, E., Maitland, S., Chen, Z., Cao, Y., Emmanouela Tsagkaraki, Wolfe, S. A., Wang, D., Pai, A. A., Xue, W., Gao, G., & Sontheimer, E. J. (2021). Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-26518-y
Li, N., Gou, S., Wang, J., Zhang, Q., Huang, X., Xie, J., Li, L., Qiu, J., Ouyang, Z., Chen, F., Ge, W., Shi, H., Liang, Y., Zhuang, Z., Zhao, X., Lian, M., Ye, Y., Quan, L., Wu, H., & Lai, L. (2021). CRISPR/Cas9-Mediated Gene Correction in Newborn Rabbits with Hereditary Tyrosinemia Type I. Molecular Therapy, 29(3), 1001–1015. https://doi.org/10.1016/j.ymthe.2020.11.023
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., … Seubert, P. (1999). Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 400(6740), 173–177. https://doi.org/10.1038/22124
Poojitha Pinjala, Kamatham Pushpa Tryphena, Prasad, R. M., Dharmendra Kumar Khatri, Sun, W., Shashi Bala Singh, Dalapathi Gugulothu, Srivastava, S., & Vora, L. K. (2023). CRISPR/Cas9 assisted stem cell therapy in Parkinson’s disease. Biomaterials Research,27(1).https://doi.org/10.1186/s40824-023-00381-y
LEI Ting, XIAO Bin, HE Yongyin, QU Jing, SUN Zhaohui, LI Linhai. Development and applications of CRISPR/Cas9 library screening technology in cancer research. Journal of Southern Medical University, 2019, 39(11): 1381-1386. DOI: 10.12122/j.issn.1673-4254.2019.11.18.
Gao, Q., Wang, K., Liang, L., Zhang, Y., Zheng, Y., & Tang, N. (2017). Constructing an arid2 knockout model based on the CRISPR/cas9 system and exploring its effects on the proliferation and migration ability of hepatocellular carcinoma cells. Journal of Chongqing Medical University (7), 850-855.
Zhou, W., Wan, Y., Guo, R., Deng, M., Deng, K., Wang, Z., Zhang, Y., & Wang, Z. (2017). Generation of beta-lactoglobulin knock-out goats using CRISPR/Cas9. PLOS ONE, 12(10), e0186056–e0186056. https://doi.org/10.1371/journal.pone.0186056
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
